KATP channel-dependent metaboproteome decoded: Systems approaches to heart failure prediction, diagnosis, and therapy

Cardiovascular Research

Volumn 90, Issue 2, 2011, Pages 258-266

  Arrell, D Kent ^a,b   Zlatkovic Lindor, Jelena ^a,b   Yamada, Satsuki ^a,b   Terzic, Andre ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

ATP sensitive K+ channel; Bioinformatics; Cardiac; Genetics; Heart disease; KATP channel; Kir6.2; Metabolism; Networks; Protein expression; Proteomics; Regenerative medicine; Stem cells; SUR2A; Systems biology

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; PROTEOME;

ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; EMBRYONIC STEM CELL; FIBROSIS; GENE SILENCING; HEART FAILURE; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; POTASSIUM CHANNELOPATHY; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; HEART FAILURE; HUMANS; METABOLOMICS; POTASSIUM CHANNELS; PREDICTIVE VALUE OF TESTS; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 79955444666     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr046     Document Type: Article

References (91)

1. Feero WG, Guttmacher AE, Collins FS. Genomic medicine\an updated primer. N Engl J Med 2010;362:2001-2011.
2. Waldman SA, Terzic A. Molecular therapeutics from knowledge to delivery. Clin Phar-macol Ther 2010;87:619-623.
3. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009;461:724-726.
4. Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci 2010;3:254-257.
5. TP channels. Mol Psychiatry 2003;8:253-254. (Pubitemid 36712915)
6. Ashcroft FM. From molecule to malady. Nature 2006;440:440-447.
7. TP channels as molecular sensors ofcellular metabolism. Nature 2006; 440:470-476.
8. ATP channels process nucleotide signals in muscle thermogenic response. Crit Rev Biochem Mol Biol 2010;45:506-519.
9. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ et al. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA 2002;99:13278-13283.
10. + channels control energy expenditure determining body weight. Cell Metab 2010;11:58-69.
11. ATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 2010;90:799-829.
12. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III, González G et al. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-426.
13. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270:1166-1170.
14. + channels. Neuron 1996;16:1011-1017. (Pubitemid 26171205)
15. + channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol 1999;31:425-434. (Pubitemid 29089890)
16. + chan-nels. In: Kew J, Davies C, eds. Ion Channels: From Structure to Function. 1st ed. Oxford: Oxford University Press; 2009. p454-473.
17. ATP channel SUR2A nucleotide binding domains resolved by synchrotron radiation X-ray scattering. J Struct Biol 2010;169: 243-251.
18. + channels in cardiac muscle. Nature 1983;305:147-148. (Pubitemid 14235671)
19. ATP channels and sulphonylurea recep-tors in the pancreatic beta-cell: new targets for oral antidiabetic agents. Curr Med Chem 2004;11:2707-2716. (Pubitemid 39255558)
20. ATP channels in health and disease. J Mol Cell Cardiol 2005;38:937-943. (Pubitemid 40725941)
21. ATP channelopathies: diseases of metabolic homeosta-sis. Pflugers Arch 2010;460:295-306.
22. Grover GJ, Dzwonczyk S, Parham CS, Sleph PG. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 1990;4:465-474. (Pubitemid 20208398)
23. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
24. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588. (Pubitemid 36885888)
25. Halkos ME, Kerendi F, Corvera JS, Wang NP, Kin H, Payne CS et al. Myocardial pro-tection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004;78:961-969. (Pubitemid 39164812)
26. Yang X-M, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004;44:1103-1110. (Pubitemid 39165147)
27. Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP et al. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol 2003;284:H2106-H2113. (Pubitemid 36622422)
28. ATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. Am J Physiol Heart Circ Physiol 2007;292:H1706-H1713. (Pubitemid 46572392)
29. ATP channel gating. Nat Genet 2004;36:382-377.
30. ATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med 2007;4:110-116. (Pubitemid 46165273)
31. ATP channel polymorphism is associated with left ventricular size in hypertensive individ-uals: a large-scale community-based study. Hum Genet 2008;123:665-667.
32. ATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response. Hum Genet 2009;126:779-789.
33. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med 2010;2:42ps37.
34. + channel knockout induces cardiac proteome remodeling predictive of heart disease suscepti-bility. J Proteome Res 2009;8:4823-4834.
35. ATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics 2009;9:1314-1325.
36. + channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy. Stem Cells 2010;28:1355-1367.
37. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-643. (Pubitemid 39440903)
38. Weston AD, Hood L Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004;3:179-196. (Pubitemid 38500984)
39. Hood L, Perlmutter RM. The impact ofsystems approaches on biological problems in drug discovery. Nat Biotechnol 2004;22:1215-1217. (Pubitemid 39336768)
40. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. The human disease network. Proc Natl Acad Sci USA 2007;104:8685-8690. (Pubitemid 47175372)
41. Kohl P, Noble D. Systems biology and the virtual physiological human. Mol Syst Biol 2009;5:292.
42. Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther 2010;88:120-125.
43. Arrell DK, Neverova I, Van Eyk JE. Cardiovascular proteomics: evolution and poten-tial. Circ Res 2001;88:763-773.
44. Barabási A-L, Oltvai ZN. Network biology: understanding the cell's functional organ-ization. Nat Rev Genet 2004;5:101-113. (Pubitemid 38160277)
45. Newman MEJ. The structure and function of complex networks. SIAM Rev 2003;45: 167-256.
46. Pawson T, Linding R. Network medicine. FEBS Lett 2008;582:1266-1270.
47. + channel in vivo. FASEBJ 2002;16: 102-104.
48. ATP channel macromolecular complex and regulate its function. J Biol Chem 2005;280: 38464-38470. (Pubitemid 43853744)
49. ATP channel. EMBO Rep 2005;6:848-852. (Pubitemid 43108675)
50. ATP channels in the heart. Circ Res 2001;88:918-924. (Pubitemid 32441470)
51. Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B et al. Coupling of cell energetics with membrane metabolic sensing: integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out J Biol Chem 2002;277:24427-24434. (Pubitemid 34951966)
52. ATP channel subunit essential for cell protection against ischemia. EMBO J 2002;21:3936-3948. (Pubitemid 34857427)
53. + channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol 2005;38:895-905. (Pubitemid 40725937)
54. ATP channels integrated with creatine and adenylate kinases: amplification, tuning and sensing of energetic signals in the compartmentalized cellular environment. Mol Cell Biochem 2004;256-257:243-256. (Pubitemid 38181249)
55. ATP channel-dependent stress tol-erance. EMBO J 2003;22:1732-1742. (Pubitemid 36460130)
56. Bell J. Predicting disease using genomics. Nature 2004;429:453-456. (Pubitemid 38715139)
57. Kostis JB. From hypertension to heart failure: update on the management ofsystolic and diastolic dysfunction. Am J Hypertens 2003;16:18S-22S. (Pubitemid 37175981)
58. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003;362:147-158. (Pubitemid 36831029)
59. Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hypertens 2008;26:1477-1486.
60. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K et al. Heart disease and stroke statistics\2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-e181.
61. Towbin JA, Bowles NE. The failing heart. Nature 2002;415:227-233. (Pubitemid 34059529)
62. Susic D, Frohlich ED. The aging hypertensive heart: a brief update. Nat Clin Pract Car-diovasc Med 2008;5:104-110. (Pubitemid 351168065)
63. Chien KR. Stress pathways and heart failure. Cell 1999;98:555-558. (Pubitemid 29418947)
64. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-556. (Pubitemid 32201949)
65. ATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet 2006;15:2285-2297. (Pubitemid 44288675)
66. Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR et al. Aden-ylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci USA 2001;98:7623-7628. (Pubitemid 32567998)
67. Weiss JN, Yang L, Qu Z. Network perspectives of cardiovascular metabolism. J Lipid Res 2006;47:2355-2366.
68. Nykter M, Price ND, Aldana M, Ramsey SA, Kauffman SA, Hood LE et al. Gene expression dynamics in the macrophage exhibit criticality. Proc Natl Acad Sci USA 2008;105:1897-1900. (Pubitemid 351439436)
69. Ashrafian H, Watkins H. Cardiomyopathies: therapeutics based on molecular pheno-type. J Am Coll Cardiol 2007;49:1251-1264.
70. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583. (Pubitemid 40322227)
71. Passier R, van Laake LW, Mummery CL Stem cell-based therapy and lessons from the heart. Nature 2008;453:322-329. (Pubitemid 351693138)
72. Segers VF, Lee RT. Stem cell therapy for cardiac disease. Nature 2008;451:937-942. (Pubitemid 351301749)
73. Hansson EM, Lindsay ME, Chien KR. Regeneration next: toward heart stem cell thera-peutics. Cell Stem Cell 2009;5:364-377.
74. Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Stem cell platforms for regenerative medicine. Clin Transl Sci 2009;2:222-227.
75. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006;113:1451-1463. (Pubitemid 43739442)
76. Torella D, Ellison GM, Méndez-Ferrer S, Ibanez B, Nadal-Ginard B. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med 2006;3:s8-s13.
77. Kajstura J, Hosoda T, Bearzi C, Rota M, Maestroni S, Urbanek K et al. The human heart: a self-renewing organ. Clin Transl Sci 2008;1:80-86.
78. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
79. De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L et al. Anthracy-cline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 2010;121:276-292.
80. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T et al. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 2008;26: 2644-2653.
81. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004;287:H471-H479. (Pubitemid 38955274)
82. Ménard C, Hagège AA, Agbulut O, Barro M, Morichetti MC, Brasselet C et al. Trans-plantation ofcardiac-committed mouse embryonic stem cells to infarcted sheep myo-cardium: a preclinical study. Lancet 2005;366:1005-1012. (Pubitemid 41323036)
83. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM et al. Engraft-ment of engineered ES cell-derived cardiomyocytes but not BM cells restores con-tractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327. (Pubitemid 44498366)
84. Chung S, Dzeja PP, Faustino RS, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007;4:s60-s67. (Pubitemid 46151906)
85. Chung S, Arrell DK, Faustino RS, Terzic A, Dzeja PP. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol 2010;48:725-734.
86. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al. Car-diomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024. (Pubitemid 47517637)
87. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G et al. Electromechanical integration ofcardiomyocytes derived from human embryonic stem cells. Nat Biotech-nol 2004;22:1282-1289. (Pubitemid 39341201)
88. + cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc Res 2007;76:119-131. (Pubitemid 47362035)
89. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S et al. Car-diopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 2007;204:405-420. (Pubitemid 46294555)
90. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction with human stemness factors induced pluirpo-tent stem cells. Circulation 2009;120:408-416.
91. + channels in pressure overload-induced con-gestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol 2006;577: 1053-1065. (Pubitemid 44873665)